Anti-Tigit Antigen-Binding Proteins And Methods Of Use Thereof

text
October 14, 2018

Inventors

Philipp Steiner, Nels P. NIELSON, Daniel Hicklin, Cynthia Seidel-Dugan, William Winston, Heather BRODKIN, Jose-Andres Salmeron-Garcia, Christopher James NIRSCHL

Assignees

  1. Potenza Therapeutics, Inc., 1030 Massachusetts Avenue, Suite 210, Cambridge, MA 02139 (US)

Abstract

Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.

CovalX Technology Used

Epitope Mapping

Patent Number

WO 2018/183889 Al

Contact our Scientific Team to Start the Conversation

Request A Call
Back
Categories : Patents, Epitope Mapping
text
PREVIOUS : Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance
NEXT : Imaging of Protein Distribution in Tissues Using Mass Spectrometry: An Interdisciplinary Challenge
text